Kidney News and Research

RSS

BWH performs New England's first implant of SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women's Hospital in Boston has performed New England's first implant of the SynCardia temporary Total Artificial Heart.

11 Jul 2012

HIV infection risk reduced by same drugs that treat HIV

People at high risk of HIV infection can reduce their risk of acquiring the disease by taking antiretroviral drugs, according to Cochrane researchers. In an update of a systematic review first published in 2009, the researchers found that uninfected people in relationships with HIV-infected partners, men who have sex with men and those in other high risk groups are at a lower risk of becoming infected with the virus if they regularly take drugs that are normally prescribed to treat people with HIV.

11 Jul 2012

New CBO numbers on health law expected soon, a GOP-led Senate would focus on cost control

This Capitol Hill news roundup includes reports about new health law budget numbers, and about how the GOP -- if it gained control of the Senate -- would focus on health care cost control rather than coverage expansion. Also in the news, Sen. Charles Grassley, R-Iowa, is proceeding with his questions about nonprofit hospitals and charity care. Finally, an ethics panel inquiry regarding a Nevada lawmaker moves forward.

11 Jul 2012

Research finds new single-gene cause of chronic kidney disease

A new single-gene cause of chronic kidney disease has been discovered that implicates a disease mechanism not previously believed to be related to the disease, according to new research from the University of Michigan.

11 Jul 2012

Nutrient cocktail can boost memory in patients with mild cognitive impairment

A clinical trial of an Alzheimer's disease treatment developed at MIT has found that the nutrient cocktail can improve memory in patients with early Alzheimer's. The results confirm and expand the findings of an earlier trial of the nutritional supplement, which is designed to promote new connections between brain cells.

11 Jul 2012

Kidney treatment could affect mouth health

Study results indicate a positive association between the type of treatment modality chronic kidney disease patients receive and the likelihood for them having periodontitis.

10 Jul 2012

First Edition: July 10, 2012

Today's headlines include findings of a new Washington Post poll indicating Americans remain divided on the health law. Meanwhile, on Capitol Hill, cracks may be emerging in the Republican's repeal effort.

10 Jul 2012

Lipid ceramide helps cells keep cilium or antenna from retracting

A lipid that helps lotion soften the skin also helps cells find and stay in the right location in the body by ensuring they keep their "antennae" up, scientists report.

10 Jul 2012

Scientists develop novel anticancer drug designed to travel through the bloodstream

Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by specific cancer proteins.

10 Jul 2012

Measuring creatinine and cystatin C more accurately estimates kidney function

Measuring creatinine and cystatin C - two markers for chronic kidney disease (CKD) - more precisely estimates kidney function than either marker alone, according to a study funded by the National Institutes of Health. Results appear in the July 5 issue of the New England Journal of Medicine.

10 Jul 2012

Ampio announces results from Optina trial on DME

Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead drugs (Ampion, Optina & Zertane), announced the significant results from their further analysis of its Optina trial on DME.

9 Jul 2012

Targeting double-stranded RNA dependent protein kinase could treat inflammation

Researchers at The Feinstein Institute for Medical Research have discovered that inflammation could be treated by targeting a molecule called the double-stranded RNA dependent protein kinase (PKR). These findings are published in the July issue of Nature.

9 Jul 2012

Robot assists in complex uro surgery for pediatric patient

Pediatric specialists of Apollo Hospitals successfully completed a complex surgery on the bladder base of a 7 year old child from Africa with the assistance of a Robot. The child's urethra, the tube from the urinary bladder, was crushed in a road accident.

7 Jul 2012

AHF calls for reasonable pricing of Gilead’s Quad AIDS drug

Today AIDS Healthcare Foundation, in response to recent press reports regarding drug manufacturer Gilead Sciences, Inc.'s new four-drug HIV/AIDS pill, known as the "Quad," renewed its call for company to price the drug reasonably, particularly in light of the fact that it represents only a marginal improvement over existing medications.

7 Jul 2012

Roche receives FDA approval for CMV viral load test

The U.S. Food and Drug Administration today approved the first DNA test to help health care professionals gauge the progress of anti-viral treatment in solid organ transplant patients undergoing cytomegalovirus (CMV) antiviral therapy.

6 Jul 2012

Obesity increases risk of AKI following cardiac surgery

Obesity increases the risk of acute kidney injury (AKI) following cardiac surgery, according to a Vanderbilt study published in the Journal of the American Society of Nephrology.

6 Jul 2012

Hearing loss linked to Alzheimer's, heart disease, chronic kidney diseases and diabetes

Ear plug retailer, All Ear Plugs, urges Brits to take more care in protecting their ears following the release of data from the Better Hearing Institute (BHI) in the US linking hearing loss to chronic diseases.

2 Jul 2012

Surgical injury is increasing dialysis use

Acute dialysis use in patients who experience kidney injury while undergoing major elective surgery has increased substantially over the past 14 years, report researchers in the Canadian Medical Association Journal.

29 Jun 2012

Once-daily pill for HIV is a safe and effective alternative to traditional antiretroviral regimens

A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week’s Lancet also indicate that the new “Quad” pill is faster acting, doesn’t have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.

29 Jun 2012

Astellas Pharma receives FDA approval for Myrbetriq to treat overactive bladder

The U.S. Food and Drug Administration today approved Myrbetriq (mirabegron) to treat adults with overactive bladder, a condition in which the bladder muscle cannot be controlled, squeezes too often or squeezes without warning.

29 Jun 2012